Impax Laboratories Inc. (IPXL) Reports Q4 EPS of $0.33, Sales Top Expectations

Impax Laboratories Inc. (NASDAQ: IPXL) reported Q4 EPS of $0.33, which may not compare to the analyst estimate of $0.22. Revenue for the quarter came in at $158.6 million versus the consensus estimate of $128.51 million.

For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Okta upgraded as AI security opportunity boosts outlook
• Bernstein SocGen on Intuitive Surgical (ISRG): 'We see $400 as a great entry point'
• KeyBanc Reiterates Overweight Rating on Magnolia Oil & Gas Corp. (MGY)